Alessandro Riva
CIK: 0001867172
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 11, 2026ONC
BeOne Medicines Ltd.
Award(A)Direct19K shares- - Jun 11, 2026IPSC
Century Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
74K shares- - May 22, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct212 shares at avg. $309.51$66K - Jan 2, 2026BCYC
BICYCLE THERAPEUTICS PLC
Award(A)Direct7.4K shares- - Jun 12, 2025IPSC
Century Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
44K shares- - May 21, 2025BGNE
BeiGene, Ltd.
Award(A)Direct11K shares- - Mar 25, 2025BCYC
BICYCLE THERAPEUTICS PLC
Award(A)Direct12.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  ONC BeOne Medicines Ltd. | Award(A) | 18,980 | - | $0 | Direct |
| Jun 11, 2026 |  IPSC Century Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 74,000 | - | - | Direct |
| May 22, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 212 | $309.51 | $65,617 | Direct |
| Jan 2, 2026 |  BCYC BICYCLE THERAPEUTICS PLC | Award(A) | 7,380 | - | $0 | Direct |
| Jun 12, 2025 | IPSC Century Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 44,000 | - | - | Direct |
| May 21, 2025 |  BGNE BeiGene, Ltd. | Award(A) | 10,985 | - | - | Direct |
| Mar 25, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Award(A) | 12,500 | - | - | Direct |
1-7 of 7 transactions
About Riva Alessandro
Riva Alessandro (SEC CIK 0001867172) files insider reports with the SEC as Director of BeOne Medicines Ltd. (ONC), Director of Century Therapeutics, Inc. (IPSC) and Director of BICYCLE THERAPEUTICS PLC (BCYC).
Signal8 holds 8 ownership filings by Riva Alessandro (1 Form 3, 7 Form 4), filed between Mar 27, 2025 and Jun 15, 2026. Those filings report 7 transactions, from Mar 25, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Riva Alessandro's filings is in PHILADELPHIA, PA.
Recent filings by Riva Alessandro
- Jun 11, 2026: Grant or award of ONC shares (Form 4, code A).
- Jun 11, 2026: Grant or award of IPSC derivative securities (Form 4, code A).
- May 22, 2026: Open-market sale of ONC shares (Form 4, code S).
- Jan 2, 2026: Grant or award of BCYC shares (Form 4, code A).
- Jun 12, 2025: Grant or award of IPSC derivative securities (Form 4, code A).
Other insiders filing for BeOne Medicines Ltd. (ONC)
- Wang Xiaodong, Director
- Lee Chan Henry, SVP, General Counsel
- Ball Titus B., Principal Accounting Officer
- Wu Xiaobin, President and COO
- OYLER JOHN, Chief Executive Officer
- Rosenberg Aaron, Chief Financial Officer